TrialMed (New York, N.Y.)2021

Metreleptin therapy for nonalcoholic steatohepatitis: Open-label therapy interventions in two different clinical settings.

Baris Akinci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.